Pusalkar, Sandeepraj et al
"Biotransformation Pathways and Metabolite Profiles of Oral [14C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors." Drug Metabolism and Disposition
48.3
(2020):
217-229.
Web. 18 Jan. 2021.
